Fuhrmann, D., Madsen, K. S., Johansen, L. B., Baaré, W. F. C. & Kievit, R. A. The midpoint of cortical thinning between late childhood and early adulthood differs between individuals and brain regions: evidence from longitudinal modelling in a 12-wave neuroimaging sample. NeuroImage 261, 119507 (2022).
Fjell, A. M. et al. Development and aging of cortical thickness correspond to genetic organization patterns. Proc. Natl Acad. Sci. USA 112, 15462–15467 (2015).
Amlien, I. K. et al. Organizing principles of human cortical development—thickness and area from 4 to 30 years: insights from comparative primate neuroanatomy. Cereb. Cortex 26, 257–267 (2016).
Paus, T., Keshavan, M. & Giedd, J. N. Why do many psychiatric disorders emerge during adolescence? Nat. Rev. Neurosci. 9, 947–957 (2008).
Huttenlocher, P. R. & Dabholkar, A. S. Regional differences in synaptogenesis in human cerebral cortex. J. Comp. Neurol. 387, 167–178 (1997).
Huttenlocher, P. R. Synaptic density in human frontal cortex—developmental changes and effects of aging. Brain Res. 163, 195–205 (1979).
Parker, N. et al. Assessment of neurobiological mechanisms of cortical thinning during childhood and adolescence and their implications for psychiatric disorders. JAMA Psychiatry 77, 1127–1136 (2020).
Petanjek, Z. et al. Extraordinary neoteny of synaptic spines in the human prefrontal cortex. Proc. Natl Acad. Sci. USA 108, 13281–13286 (2011).
Tamnes, C. K. et al. Development of the cerebral cortex across adolescence: a multisample study of inter-related longitudinal changes in cortical volume, surface area, and thickness. J. Neurosci. 37, 3402–3412 (2017).
Bethlehem, R. A. I. et al. Brain charts for the human lifespan. Nature 604, 525–533 (2022).
Zhao, Q. et al. The ABCD Study: brain heterogeneity in intelligence during a neurodevelopmental transition stage. Cereb. Cortex 32, 3098–3109 (2022).
Kuang, N. et al. Neurodevelopmental risk and adaptation as a model for comorbidity among internalizing and externalizing disorders: genomics and cell-specific expression enriched morphometric study. BMC Med. 21, 291 (2023).
Romer, A. L., Ren, B. & Pizzagalli, D. A. Brain structure relations with psychopathology trajectories in the ABCD Study. J. Am. Acad. Child Adolesc. Psychiatry 62, 895–907 (2023).
Bos, M. G. N., Peters, S., van de Kamp, F. C., Crone, E. A. & Tamnes, C. K. Emerging depression in adolescence coincides with accelerated frontal cortical thinning. J. Child Psychol. Psychiatry 59, 994–1002 (2018).
Yu, G. et al. Common and disorder-specific cortical thickness alterations in internalizing, externalizing and thought disorders during early adolescence: an Adolescent Brain and Cognitive Development study. J. Psychiatry Neurosci. 48, E345–E356 (2023).
Stevens, B. et al. The classical complement cascade mediates CNS synapse elimination. Cell 131, 1164–1178 (2007).
Bohlson, S. S. & Tenner, A. J. Complement in the brain: contributions to neuroprotection, neuronal plasticity, and neuroinflammation. Annu. Rev. Immunol. https://doi.org/10.1146/annurev-immunol-101921-035639 (2023).
Vidal-Pineiro, D. et al. Cellular correlates of cortical thinning throughout the lifespan. Sci. Rep. 10, 21803 (2020).
Vainchtein, I. D. et al. Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development. Science 359, 1269–1273 (2018).
Miller, A. H. & Raison, C. L. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat. Rev. Immunol. 16, 22–34 (2016).
Riester, K. et al. In vivo characterization of functional states of cortical microglia during peripheral inflammation. Brain Behav. Immun. 87, 243–255 (2020).
Goldsmith, D. R., Bekhbat, M., Mehta, N. D. & Felger, J. C. Inflammation-related functional and structural dysconnectivity as a pathway to psychopathology. Biol. Psychiatry 93, 405–418 (2023).
Barker, E. D. et al. Inflammation-related epigenetic risk and child and adolescent mental health: a prospective study from pregnancy to middle adolescence. Dev. Psychopathol. 30, 1145–1156 (2018).
Jones, H. J. et al. Association of genetic risk for rheumatoid arthritis with cognitive and psychiatric phenotypes across childhood and adolescence. JAMA Netw. Open 2, e196118 (2019).
Hurlimann, J., Thorbecke, G. J. & Hochwald, G. M. The liver as the site of C-reactive protein formation. J. Exp. Med. 123, 365–378 (1966).
Rhodes, B., Furnrohr, B. G. & Vyse, T. J. C-reactive protein in rheumatology: biology and genetics. Nat. Rev. Rheumatol. 7, 282–289 (2011).
Baumann, H. & Gauldie, J. The acute phase response. Immunol. Today 15, 74–80 (1994).
Felger, J. C. et al. What does plasma CRP tell us about peripheral and central inflammation in depression? Mol. Psychiatry 25, 1301–1311 (2020).
Ironside, M. et al. Inflammation and depressive phenotypes: evidence from medical records from over 12 000 patients and brain morphology. Psychol. Med. 50, 2790–2798 (2020).
Zheng, H. et al. C-Reactive protein and the kynurenic acid to quinolinic acid ratio are independently associated with white matter integrity in major depressive disorder. Brain Behav. Immun. 105, 180–189 (2022).
Pitharouli, M. C. et al. Elevated C-reactive protein in patients with depression, independent of genetic, health, and psychosocial factors: results from the UK Biobank. Am. J. Psychiatry 178, 522–529 (2021).
Osimo, E. F., Baxter, L. J., Lewis, G., Jones, P. B. & Khandaker, G. M. Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels. Psychol. Med. 49, 1958–1970 (2019).
Fernandes, B. S. et al. C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis. Lancet Psychiatry 3, 1147–1156 (2016).
Fernandes, B. S. et al. C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications. Mol. Psychiatry 21, 554–564 (2016).
Figueroa-Hall, L. K. et al. Psychiatric symptoms are not associated with circulating CRP concentrations after controlling for medical, social, and demographic factors. Transl. Psychiatry 12, 279 (2022).
Said, S. et al. Genetic analysis of over half a million people characterises C-reactive protein loci. Nat. Commun. 13, 2198 (2022).
Mac Giollabhui, N. et al. Role of inflammation in depressive and anxiety disorders, affect, and cognition: genetic and non-genetic findings in the lifelines cohort study. Transl. Psychiatry 15, 164 (2025).
Benros, M. E. et al. Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry 70, 812–820 (2013).
Köhler-Forsberg, O. et al. A nationwide study in Denmark of the association between treated infections and the subsequent risk of treated mental disorders in children and adolescents. JAMA Psychiatry 76, 271–279 (2019).
Bilbo, S. D. & Schwarz, J. M. Early-life programming of later-life brain and behavior: a critical role for the immune system. Front. Behav. Neurosci. 3, 14 (2009).
Bland, S. T. et al. Enduring consequences of early-life infection on glial and neural cell genesis within cognitive regions of the brain. Brain Behav. Immun. 24, 329–338 (2010).
Lavebratt, C. et al. Early exposure to antibiotic drugs and risk for psychiatric disorders: a population-based study. Transl. Psychiatry 9, 317 (2019).
De Los Reyes, A. et al. The validity of the multi-informant approach to assessing child and adolescent mental health. Psychol. Bull. 141, 858–900 (2015).
Marek, S. et al. Reproducible brain-wide association studies require thousands of individuals. Nature 603, 654–660 (2022).
Dick, A. S. et al. Meaningful associations in the Adolescent Brain Cognitive Development Study. NeuroImage 239, 118262 (2021).
Youjin, Z. et al. Cortical thickness abnormalities at different stages of the illness course in schizophrenia. JAMA Psychiatry 79, 560–570 (2022).
Erp, T. V. V. et al. Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 control subjects via the enhancing neuro imaging genetics through meta analysis (ENIGMA) consortium. Biol. Psychiatry 84, 644–654 (2018).
Roberts, G. et al. Accelerated cortical thinning and volume reduction over time in young people at high genetic risk for bipolar disorder. Psychol. Med. 52, 1344–1355 (2020).
Baselmans, B. et al. The genetic and neural substrates of externalizing behavior. Biol. Psychiatry Glob. Open Sci. 2, 389–399 (2022).
Tandberg, A. D. et al. Individual differences in internalizing symptoms in late childhood: a variance decomposition into cortical thickness, genetic and environmental differences. Dev Sci. https://doi.org/10.1111/desc.13537 (2024).
Bhaya-Grossman, I. & Chang, E. F. Speech computations of the human superior temporal gyrus. Annu. Rev. Psychol. 73, 79–102 (2022).
Uddin, L. Q. Salience processing and insular cortical function and dysfunction. Nat. Rev. Neurosci. 16, 55–61 (2015).
Kristina, D., Ferris, C. & Hamann, S. Neural correlates of successful emotional episodic encoding and retrieval: an SDM meta-analysis of neuroimaging studies. Neuropsychologia https://doi.org/10.1016/j.neuropsychologia.2020.107495 (2020).
Hernandez, L. M. et al. Multi-ancestry phenome-wide association of complement component 4 variation with psychiatric and brain phenotypes in youth. Genome Biol. 24, 42 (2023).
O’Connell, K. S. et al. Association between complement component 4A expression, cognitive performance and brain imaging measures in UK Biobank. Psychol. Med. 52, 1–11 (2021).
Zeng, Y. et al. Inflammatory biomarkers and risk of psychiatric disorders. JAMA Psychiatry https://doi.org/10.1001/jamapsychiatry.2024.2185 (2024).
Dantzer, R., O’Connor, J. C., Freund, G. G., Johnson, R. W. & Kelley, K. W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9, 46–56 (2008).
Guerrin, C. G. J., Doorduin, J., Sommer, I. E. & de Vries, E. F. J. The dual hit hypothesis of schizophrenia: evidence from animal models. Neurosci. Biobehav. Rev. 131, 1150–1168 (2021).
Neher, J. J. & Cunningham, C. Priming microglia for innate immune memory in the brain. Trends Immunol. 40, 358–374 (2019).
Howes, O. D., McCutcheon, R., Owen, M. J. & Murray, R. M. The role of genes, stress, and dopamine in the development of schizophrenia. Biol. Psychiatry 81, 9–20 (2017).
Haroon, E. et al. Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia. Transl. Psychiatry 8, 189 (2018).
Haroon, E., Miller, A. H. & Sanacora, G. Inflammation, glutamate, and glia: a trio of trouble in mood disorders. Neuropsychopharmacology 42, 193–215 (2017).
Felger, J. C. et al. Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol. Psychiatry 21, 1358–1365 (2016).
Felger, J. C. & Treadway, M. T. Inflammation effects on motivation and motor activity: role of dopamine. Neuropsychopharmacology 42, 216–241 (2017).
Glass, D. et al. Gene expression changes with age in skin, adipose tissue, blood and brain. Genome Biol. 14, R75 (2013).
Makowski, C. et al. Discovery of genomic loci of the human cerebral cortex using genetically informed brain atlases. Science 375, 522–528 (2022).
Jansen, A. G. et al. The predictive capacity of psychiatric and psychological polygenic risk scores for distinguishing cases in a child and adolescent psychiatric sample from controls. J. Child Psychol. Psychiatry 62, 1079–1089 (2021).
Duncan, L. et al. Analysis of polygenic risk score usage and performance in diverse human populations. Nat. Commun. 10, 3328 (2019).
Ahern, J., Thompson, W., Fan, C. C. & Loughnan, R. Comparing pruning and thresholding with continuous shrinkage polygenic score methods in a large sample of ancestrally diverse adolescents from the ABCD Study®. Behav. Genet. 53, 292–309 (2023).
Garavan, H. et al. Recruiting the ABCD sample: design considerations and procedures. Dev. Cogn. Neurosci. 32, 16–22 (2018).
Casey, B. J. et al. The Adolescent Brain Cognitive Development (ABCD) study: imaging acquisition across 21 sites. Dev. Cogn. Neurosci. 32, 43–54 (2018).
Sollis, E. et al. The NHGRI-EBI GWAS Catalog: knowledgebase and deposition resource. Nucleic Acids Res. 51, D977–D985 (2023).
Gadin, J., Zetterberg, R., Meijsen, J. & Schork, A. Cleansumstats: converting GWAS sumstats to a common format to facilitate downstream applications. Zenodo https://zenodo.org/records/7540572 (2023).
Uban, K. A. et al. Biospecimens and the ABCD study: rationale, methods of collection, measurement and early data. Dev. Cogn. Neurosci. 32, 97–106 (2018).
Baurley, J. W., Edlund, C. K., Pardamean, C. I., Conti, D. V. & Bergen, A. W. Smokescreen: a targeted genotyping array for addiction research. BMC Genomics 17, 145 (2016).
Taliun, D. et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature 590, 290–299 (2021).
Chen, C. Y. et al. Improved ancestry inference using weights from external reference panels. Bioinformatics 29, 1399–1406 (2013).
Auton, A. et al. A global reference for human genetic variation. Nature 526, 68–74 (2015).
Reich, D. et al. Reconstructing Native American population history. Nature 488, 370–374 (2012).
Ge, T., Chen, C. Y., Ni, Y., Feng, Y. A. & Smoller, J. W. Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat. Commun. 10, 1776 (2019).
Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience 4, 7 (2015).
Hagler, D. J. Jr. et al. Image processing and analysis methods for the Adolescent Brain Cognitive Development Study. NeuroImage 202, 116091 (2019).
Desikan, R. S. et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage 31, 968–980 (2006).
Achenbach, T. M. & Ruffle, T. M. The child behavior checklist and related forms for assessing behavioral/emotional problems and competencies. Pediatr. Rev. 21, 265–271 (2000).
Achenbach, T. M., Ivanova, M. Y., Rescorla, L. A., Turner, L. V. & Althoff, R. R. Internalizing/externalizing problems: review and recommendations for clinical and research applications. J. Am. Acad. Child Adolesc. Psychiatry 55, 647–656 (2016).
Peverill, M. et al. Socioeconomic status and child psychopathology in the United States: a meta-analysis of population-based studies. Clin. Psychol. Rev. 83, 101933 (2021).
Rakesh, D., Zalesky, A. & Whittle, S. Assessment of parent income and education, neighborhood disadvantage, and child brain structure. JAMA Netw. Open 5, e2226208 (2022).
Fan, C. C., Loughnan, R., Wilson, S. & Hewitt, J. K. Genotype data and derived genetic instruments of Adolescent Brain Cognitive Development Study® for better understanding of human brain development. Behav. Genet. 53, 159–168 (2023).
Markello, R. D. et al. neuromaps: structural and functional interpretation of brain maps. Nat. Methods 19, 1472–1479 (2022).
Savli, M. et al. Normative database of the serotonergic system in healthy subjects using multi-tracer PET. NeuroImage 63, 447–459 (2012).
Beliveau, V. et al. A high-resolution in vivo atlas of the human brain’s serotonin system. J. Neurosci. 37, 120–128 (2017).
Radhakrishnan, R. et al. Age-related change in 5-HT6 receptor availability in healthy male volunteers measured with 11C-GSK215083 PET. J. Nucl. Med. 59, 1445–1450 (2018).
Normandin, M. D. Imaging the cannabinoid CB1 receptor in humans with [11C]OMAR: assessment of kinetic analysis methods, test-retest reproducibility, and gender differences. J. Cereb. Blood Flow Metab. 35, 1313–1322 (2015).
Kaller, S. et al. Test-retest measurements of dopamine D1-type receptors using simultaneous PET/MRI imaging. Eur. J. Nucl. Med. Mol. Imaging 44, 1025–1032 (2017).
Smith, C. T. et al. Partial-volume correction increases estimated dopamine D2-like receptor binding potential and reduces adult age differences. J. Cereb. Blood Flow Metab. 39, 822–833 (2019).
Dukart, J. et al. Cerebral blood flow predicts differential neurotransmitter activity. Sci. Rep. 8, 4074 (2018).
Nørgaard, M. et al. A high-resolution in vivo atlas of the human brain’s benzodiazepine binding site of GABA(A) receptors. NeuroImage 232, 117878 (2021).
Gallezot, J. D. Determination of receptor occupancy in the presence of mass dose: [11C]GSK189254 PET imaging of histamine H3 receptor occupancy by PF-03654746. J. Cereb. Blood Flow Metab. 37, 1095–1107 (2017).
Ding, Y. S. PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)-[11C]O-methylreboxetine and HRRT. Synapse 64, 30–38 (2010).
Naganawa, M. et al. First-in-human assessment of (11)C-LSN3172176, an M1 muscarinic acetylcholine receptor PET radiotracer. J. Nucl. Med. 62, 553–560 (2021).
Aghourian, M. Quantification of brain cholinergic denervation in Alzheimer’s disease using PET imaging with [18F]-FEOBV. Mol. Psychiatry 22, 1531–1538 (2017).
Smart, K. Sex differences in [11C]ABP688 binding: a positron emission tomography study of mGlu5 receptors. Eur. J. Nucl. Med. Mol. Imaging 46, 1179–1183 (2019).
Kantonen, T. et al. Interindividual variability and lateralization of μ-opioid receptors in the human brain. NeuroImage 217, 116922 (2020).
Váša, F. & Mišić, B. Null models in network neuroscience. Nat. Rev. Neurosci. 23, 493–504 (2022).